Human immunodeficiency virus/acquired immunodeficiency syndrome-related cancer in the pre- and post-highly active antiretroviral therapy era in a national cancer center of a resource-limited country: 1988 to 2007

被引：0

作者：

Cuellar Ponce de Leon, L. E., Sr. ^{[1
]}

Miranda Rosales, L. M., Sr. ^{[1
]}

Biminchumo Zagastegui, C. ^{[1
]}

Rosales Cusichaqui, R. ^{[1
]}

Flores, C., Sr. ^{[1
]}

Mas Lopez, L., Sr. ^{[1
]}

Leon Chong, J., Sr. ^{[1
]}

机构：

[1] Inst Nacl Enfermedades Neoplasicas, Lima, Peru

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e20550

引用

页数：1

共 46 条

[21] Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus/acquired immune deficiency syndrome
Venkatesh, Kartik K.
Biswas, J.
Kumarasamy, N.
INDIAN JOURNAL OF OPHTHALMOLOGY, 2008, 56 (05) : 391 - 393
[22] Human immunodeficiency virus-associated squamous cell cancer of the anus: Epidemiology and outcomes in the highly active Antiretroviral therapy era
Chiao, Elizabeth Y.
Giordano, Thomas P.
Richardson, Peter
El-Serag, Hashem B.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 474 - 479
[23] Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era
Abbott, KC
Hypolite, I
Welch, PG
Agodoa, LYC
JOURNAL OF NEPHROLOGY, 2001, 14 (05) : 377 - 383
[24] Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia
Cortes, J
Thomas, D
Rios, A
Koller, C
O'Brien, S
Jeha, S
Faderl, S
Kantarjian, H
CANCER, 2002, 94 (05) : 1492 - 1499
[25] Immune Responses to Measles and Tetanus Vaccines Among Kenyan Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Children Pre- and Post-Highly Active Antiretroviral Therapy and Revaccination
Farquhar, Carey
Wamalwa, Dalton
Selig, Sara
John-Stewart, Grace
Mabuka, Jennifer
Majiwa, Maxwel
Sutton, William
Haigwood, Nancy
Wariua, Grace
Lohman-Payne, Barbara
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : 295 - 299
[26] Effect of anthropometric and sociodemographic variables on physical activity levels of people living with human immunodeficiency virus/acquired immunodeficiency syndrome on highly active antiretroviral therapy
Anikpe, Jane Nwanneka
Chukwu, Aroh Joseph
Edem, Ekom Ndifreke
Elahmar, Adel A. E.
Sinha, Sohini
Arome, David
TZU CHI MEDICAL JOURNAL, 2023, 35 (02): : 200 - 204
[27] Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base
Olszewski, Adam J.
Fallah, Jaleh
Castillo, Jorge J.
CANCER, 2016, 122 (17) : 2689 - 2697
[28] Human Immunodeficiency Virus-Associated Primary Lung Cancer in the Era of Highly Active Antiretroviral Therapy: A Multi-Institutional Collaboration
D'Jaen, Gabriela A.
Pantanowitz, Liron
Bower, Mark
Buskin, Susan
Neil, Nancy
Greco, Erin M.
Cooley, Timothy P.
Henry, David
Stem, Jonathan
Dezube, Bruce J.
Stebbing, Justin
Aboulafia, David M.
CLINICAL LUNG CANCER, 2010, 11 (06) : 396 - 404
[29] Oral manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome and their correlation to cluster of differentiation lymphocyte count in population of North-East India in highly active antiretroviral therapy era
Nayak, Sarat Kumar
Das, Bijay Kumar
Das, Surya Narayan
Mohapatra, Namita
Nayak, Suryakanti
Bhuyan, Lipsa
CONTEMPORARY CLINICAL DENTISTRY, 2016, 7 (04) : 539 - 543
[30] Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy
Bonnet, F
Lewden, C
May, T
Heripret, L
Jougla, E
Bevilacqua, S
Costagliola, D
Salmon, D
Chêne, G
Morlat, P
CANCER, 2004, 101 (02) : 317 - 324

← 1 2 3 4 5 →